Source: International Congress 2015 – Microbial impacts at different human ages



Rating:

Share or cite this content

Citations should be made in the following way:
Gaudenz Hafen (Belmont-sur-Lausanne, Switzerland). Implications of the microbiome and mycobiome in cystic fibrosis. International Congress 2015 – Microbial impacts at different human ages

Member's Comments

No comment yet.

Related content which might interest you: The microbiome in bronchiectasis Source: ERS Lung Science Conference 2019 Year: 2019 The bronchiectasis microbiome Source: Eur Respir Monogr 2018; 81: 82-98 Year: 2018 A molecular comparison of microbial communities in bronchiectasis and cystic fibrosis Source: Eur Respir J 2013; 41: 991-993 Year: 2013 Ivacaftor/lumacaftor changes the lung microbiome and metabolome in cystic fibrosis patients Source: Virtual Congress 2020 – Advances in cystic fibrosis: from microbiome to MRI Year: 2020 Temporal progression of fungal microbiota in patients with cystic fibrosis Source: International Congress 2015 – Cystic fibrosis: assessment and treatment Year: 2015 The cystic fibrosis lower airways microbial metagenome Source: ERJ Open Res 2016: 00096-2015 Year: 2016 Influence of the lung microbiome on antibiotic susceptibility of cystic fibrosis pathogens Source: Eur Respir Rev, 28 (152) 190041; 10.1183/16000617.0041-2019 Year: 2019 Molecular detection of complex microbial communities in sputa of patients with cystic fibrosis and non cystic fibrosis bronchiectasis Source: Annual Congress 2010 - Cystic fibrosis: lung disease infection and more Year: 2010 Airway microbiota across age and disease spectrum in cystic fibrosis Source: Eur Respir J, 50 (5) 1700832; 10.1183/13993003.00832-2017 Year: 2017 Whole metagenome shotgun sequencing analysis of microbiome of cystic fibrosis- and COPD patients Source: International Congress 2014 – Cystic fibrosis: genotypes, inflammation and microbiology Year: 2014 Fungi communities detected by metagenomic tools in sputum in patients with cystic fibrosis Source: Annual Congress 2013 –Bacterial, fungal and mycobacterial infections Year: 2013 Emerging pathogens in cystic fibrosis Source: International Congress 2019 – State of the art session: Paediatric respiratory diseases Year: 2019 Fungal colonization in cystic fibrosis – correlating variables Source: International Congress 2019 – Infection and inflammation in cystic fibrosis Year: 2019 The microbiome in IPF Source: International Congress 2014 – ERS/NEJM joint lunchtime session "The changing landscape of idiopathic pulmonary fibrosis (IPF)" Year: 2014 The pulmonary microbiome in non-cystic fibrosis bronchiectasis. Source: International Congress 2017 – Bronchiectasis and NTM infections: epidemiology, phenotyping and therapeutic strategies Year: 2017 The fungal microbiome and its role in bronchiectasis Source: International Congress 2019 – State of the art session: Respiratory infections Year: 2019 Individual treatment of cystic fibrosis by using intestinal organoids Source: International Congress 2015 – Advancing therapies for cystic fibrosis Year: 2015 Cystic fibrosis patients have different microbiological colonization comparing to other bronchiectasis Source: Annual Congress 2010 - New aspects of cystic fibrosis Year: 2010 Correction of CFTR function in intestinal organoids to guide treatment of cystic fibrosis Source: Eur Respir J, 57 (1) 1902426; 10.1183/13993003.02426-2019 Year: 2021